3 Reasons Argenx Could Be a Top Biotech Stock for the Next Decade
Argenx (NASDAQ: ARGX) has been a winner for investors in recent years. Since early 2022, its shares have soared roughly 180%. That performance is roughly three times the gains delivered by the S&P 500 (SNPINDEX: ^GSPC) . But will Argenx be a top biotech stock over the next decade? Here are three reasons the answer could be a resounding "yes." Image source: Getty Images. Continue reading